Nachrichten zur Teva Pharmaceutical Industries Ltd. ADR Aktie

Teva Pharmaceutical S&P rating outlook changed to stable from positive

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Deckers (DECK) Q4 Earnings Beat Estimates, HOKA Brand Aids

Deckers Outdoors (DECK) fourth-quarter fiscal 2023 results reflect a 7.5% increase in net sales, driven by the strength of its…

Teva is Said to Explore Options for Bowel Inflammation Drug

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

TEVA Pharmaceutical: Ersteinschätzung

New York (www.aktiencheck.de) - Rating-Update: Thibault Boutherin, Analyst von Morgan Stanley, startet die Coverage der Aktie von TEVA Pharmaceutical Industries Ltd.…

Der Branchenriese Teva verliert Interesse an Generika – Medikamente dürften noch knapper werden

Medikamentenkopien können nicht billig genug sein. Der neue Chef des weltweit zweitgrössten Generikaherstellers, Teva Pharmaceuticals, zieht aus dem Preiskampf seine…

3 Generic Drug Stocks to Watch Amid Macro Headwinds

The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite…

Sun: Teva drags TASE down

Teva led the declines today as Tower and Nova bucked the market....…

Teva long-acting schizophrenia drug Uzedy reduces relapse risk up to 80%

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Watch Teva to Make Fewer Generic Drugs

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Plans to Cut Back Generic Drug Production Even As Shortages ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Will Slim Down Its Generic Drug Business

The new corporate strategy aims to deliver a “pivot to growth," the drugmaker said....…

Why Teva Pharmaceutical Stock Is Jumping Today

Investors are reacting positively to Tevas new growth strategy....…

Teva targets growth through innovation

Tevas new strategy stresses growth through branded drugs and biosimilars. The company sees Austedo sales of $2.7 billion in 2027....…

Teva gains after announcing new growth strategy; Evercore upgrades

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceutical announces new growth strategy built on biosimilars, innovation

Teva Pharmaceutical Industries on Thursday launched a new “pivot to growth” strategy, based on existing growth drivers like Austedo and…

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

...By Blake Brittain WASHINGTON (Reuters) -The U.S. Supreme Court......…

UPDATE 1-US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

... 15 (Reuters) - The U.S. Supreme Court on Monday declined to hear Teva......…

Teva-Aktie in Rot: Chef der Teva-Tochter Ratiopharm warnt vor weiteren Arzneimittel-Engpässen

Der Geschäftsführer des Ulmer Arzneimittelherstellers Ratiopharm, Andreas Burkhardt, sieht viele weitere Engpässe in der Medikamentenversorgung auf Deutschland zukommen....…

Hot Stocks: UPST, LI gain on strong earnings; CELH rise on an analyst upgrade; TWLO, TEVA, OXY slide

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceutical Industries (TEVA) Q1 2023 Earnings Call Transcript

TEVA earnings call for the period ending March 31, 2023....…

Compared to Estimates, Teva Pharmaceutical Industries Ltd. (TEVA) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Teva Pharmaceutical Industries Ltd. (TEVA) give a sense of how the business performed…

Teva Pharmaceutical Shares Slide 12% on 1Q Earnings Miss

Teva Pharmaceutical Shares Slide 12% on 1Q Earnings Miss...…

Teva Pharm Q1 net profit slides, maintains 2023 forecast

...JERUSALEM (Reuters) -Israel-based Teva Pharmaceutical Industries......…

UPDATE 1-Teva Pharm Q1 net profit slides, maintains 2023 forecast

... (Reuters) - Israel-based Teva Pharmaceutical Industries reported a drop......…

Teva misses on profit, beats analysts on revenue

The Israeli company reported non-GAAP earning per share of just $0.40, while market expectations were $0.56....…

ROUNDUP: Teva Pharma Reaffirms FY23 Outlook

PETAH TIKVA (dpa-AFX) - While reporting financial results for the first quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) reaffirmed…

Teva Pharm Q1 net profit slides, revenue flat

...JERUSALEM, May 10 (Reuters) - Israel-based Teva Pharmaceutical......…

Teva Pharmaceutical Industries Limited Q1 Earnings Summary

PETAH TIKVA (dpa-AFX) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):Earnings: -$205 million in Q1 vs.…

Form 8-K TEVA PHARMACEUTICAL INDU For: May 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceutical Q1 results in focus with eye on revenue numbers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

FDA approves innovative Teva schizophrenia drug

UZEDY was developed together with MedinCells copolymer technology....…

Teva, MedinCell win FDA nod for long-acting schizophrenia therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Recalls FENTANYL Buccal Tablets CII

PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals USA is recalling specific lots of various strengths of FENTANYL Buccal Tablets CII to…

Teva Recalls FENTANYL Buccal Tablets CII

Teva Pharmaceuticals USA is recalling specific lots of various strengths of FENTANYL Buccal Tablets CII to the consumer level citing…

Teva paid top executives $330m while share price tanked

Over the past 10 years, Teva has paid its top five executives huge amounts while its share price fell 72%....…

Kare Schultz earned $107m during Teva tenure

Schultz who stepped down at the end of 2022 after five years at the helm will receive a further $16…

Teva: Das macht die Aktie für gewisse Anleger interessant

Die Teva-Aktie (WKN: 883035) ist in den letzten Tagen um -13% auf aktuell 7,50 € eingebrochen. Ein aktueller Grund hierfür…

Teva Shares Drop 11% After Alvotech Gets FDA Complete Response Letter

Teva Shares Drop 11% After Alvotech Gets FDA Complete Response Letter...…

Teva down 2%after receiving FDA response letter for AVT02 biologics

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva in pact with Neurocrine to delay Ingrezza generics

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Corporate News: ART MEDICAL

ART MEDICAL Announces Partnership With Teva Israel to Bring Its Lifesaving Technology to Critical Care Units...…

ART MEDICAL Ltd: ART MEDICAL Announces Partnership With Teva Israel to Bring Its Lifesaving Technology to Critical Care Units

ART MEDICAL Ltd. is pleased to announce its collaboration with Teva Israel. Under the terms of the agreement, Teva Israel…

dpa-AFX ProFeed